Climb Bio FY2025 EPS Estimate Reduced by Leerink Partnrs
Climb Bio, Inc. (NASDAQ:CLYM – Free Report) – Research analysts at Leerink Partnrs dropped their FY2025 earnings per share (EPS) estimates for Climb Bio in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn ($0.66) per share for the year, down from their previous […]
Climb Bio, Inc. (NASDAQ:CLYM – Free Report) – Research analysts at Leerink Partnrs dropped their FY2025 earnings per share (EPS) estimates for Climb Bio in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn ($0.66) per share for the year, down from their previous […]
